July 27, 2006 • Page Image 22
…ZAVESCA,:- Adverse Reactions in 25% of Patients in Two Open-Label, Uncontrolled Monotherapy Trials of ZAVESCA' Incidence of Adverse Reaction Study 1 Study 2 (starting dose of (50 mg 11D) (miglustat) capsules Middle East 100 mg TID) ZAVESCA® [miglustat] Capsules, 100mg Brief Summary: Please see package insert for full prescribing informatiOn. INDICATION AND USAGE: ZAVESCA' is indicated for the treatment of adult patients with mild to ...…

















































